R

Rafael Holdings
D

RFL

1.83500
USD
0.05
(2.51%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-1
حجم السوق
58,802,575
أصول ذات صلة
CAT
CAT
-28.93
(-8.65%)
305.68 USD
CMI
CMI
-24.72
(-7.72%)
295.34 USD
DE
DE
-23.29
(-4.95%)
447.36 USD
DOV
DOV
-16.420
(-9.17%)
162.690 USD
GE
GE
-12.130
(-6.07%)
187.560 USD
HON
HON
-9.300
(-4.31%)
206.610 USD
IR
IR
-8.165
(-10.00%)
73.505 USD
MMM
MMM
-8.040
(-5.44%)
139.700 USD
PNR
PNR
-7.510
(-8.44%)
81.520 USD
SWK
SWK
-12.315
(-16.00%)
64.660 USD
المزيد
الأخبار المقالات

العنوان: Rafael Holdings

القطاع: Real Estate
الصناعة: Real Estate Services
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.